Drug Researcher @MannKindCorp. Pharmacist by training,MPH @BUSPH. AvGeek, F1Nerd. Outdoors is where I find my inner peace. I stand by all my tweets. #MedTwitter
MannKind is excited to announce that the U.S. Food and Drug Administration (FDA) has approved a new, transformative delivery option for the treatment of fluid buildup due to heart failure or chronic kidney disease.
Designed for ease of use, this at-home administration option is delivered subcutaneously in seconds. Learn more in the Company Announcement here: https://t.co/VXqw2KB33Y
ISI: https://t.co/VXqw2KB33Y
Prescribing info: https://t.co/D105ooNBCk
MannKind is excited to announce that the U.S. Food and Drug Administration (FDA) has approved the first needle-free treatment option for pediatric patients living with type 1 diabetes. Learn more in the Company Announcement here: https://t.co/x0TFQg3HDw
Important Safety Information: https://t.co/x0TFQg3HDw
Prescribing Information: https://t.co/2FZtyJna2E
#Press #FDA #Diabetes #T1D
@paddylowe@TheBishF1 They should just call the Race Director position “Charlie” as a colloquial title. That’ll be a great honour to a man who defined that role so well.
I believe everyone who works in Clinical Trials should have an opportunity to hear from the patients and reflect upon their tireless efforts over the years impact lives. Nothing can boost the spirits better. #HeartFailure#ClinicalTrials
https://t.co/EvV224dCFW
@TomClarksonF1 Finally the man I’ve been waiting to hear from. Thanks #F1BeyondTheGrid and TC. I always wondered who could be the one that came up with the RBPT idea. After hearing him talk about the struggles in 2014 I am sure that Adrian is a huge factor behind RB building their own engines